HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report.

AbstractBACKGROUND:
Patients with locally advanced rectal cancer (LARC) achieving a pathological complete response (pCR) to neoadjuvant treatment usually have a good prognosis, but only accounted for less than 20%.
CASE PRESENTATION:
We report a case of a 25-year-old male with LARC treated with neoadjuvant FOLFOX chemotherapy, and experienced a pCR. The next-generation sequencing analysis revealed the presence of breast cancer gene 2 (BRCA2) somatic mutation and an increased somatic mutational load without microsatellite instability (MSI). To our knowledge, this is the first report of BRCA2 mutant LARC that demonstrated significant benefit from FOLFOX neoadjuvant treatment.
CONCLUSIONS:
This case indicated an association of BRCA2 mutation with high mutation loads and an excellent response of oxaliplatin-based chemotherapy regimen for LARC. Our findings encourage further studies to analyze BRCA mutations in patients with LARC, especially for those patients unable or unwilling to receive radiotherapy.
AuthorsZhenyu Lin, Junli Liu, Li Peng, Dejun Zhang, Ming Jin, Jing Wang, Jun Xue, Hongli Liu, Tao Zhang
JournalBMC cancer (BMC Cancer) Vol. 18 Issue 1 Pg. 1253 (Dec 14 2018) ISSN: 1471-2407 [Electronic] England
PMID30547773 (Publication Type: Case Reports, Journal Article)
Chemical References
  • BRCA2 Protein
  • BRCA2 protein, human
  • Organoplatinum Compounds
  • Leucovorin
  • Fluorouracil
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • BRCA2 Protein (genetics)
  • Fluorouracil (administration & dosage, therapeutic use)
  • Humans
  • Leucovorin (administration & dosage, therapeutic use)
  • Magnetic Resonance Imaging
  • Male
  • Mutation
  • Neoadjuvant Therapy
  • Organoplatinum Compounds (administration & dosage, therapeutic use)
  • Rectal Neoplasms (diagnostic imaging, drug therapy, genetics)
  • Sequence Analysis, DNA
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: